INS and cancer: At the same time, inflammation and microbial imbalance trigger systemic endocrine and neurohormonal changes—including insulin resistance, activation of the renin-angiotensin-aldosterone system (RAAS), and increased oxidative stress—all of which are key contributors to the development of both HF and cancer [33,85,86,87,88].